Literature DB >> 28104761

What Is the Future of Cell-Based Therapy for Acute Myocardial Infarction.

Bryon A Tompkins1, Makoto Natsumeda1, Wayne Balkan1, Joshua M Hare2.   

Abstract

Entities:  

Keywords:  Editorials; clinical trial; death, sudden, cardiac; endothelial progenitor cells; myocardial infarction; stem cells

Mesh：

Year:  2017        PMID： 28104761      PMCID： PMC5261616          DOI： 10.1161/CIRCRESAHA.116.310340

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

1.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

2.  Intramyocardial, autologous CD34+ cell therapy for refractory angina.

Authors:  Douglas W Losordo; Timothy D Henry; Charles Davidson; Joon Sup Lee; Marco A Costa; Theodore Bass; Farrell Mendelsohn; F David Fortuin; Carl J Pepine; Jay H Traverse; David Amrani; Bruce M Ewenstein; Norbert Riedel; Kenneth Story; Kerry Barker; Thomas J Povsic; Robert A Harrington; Richard A Schatz
Journal:  Circ Res       Date:  2011-07-07       Impact factor: 17.367

3.  CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.

Authors:  Arshed A Quyyumi; Edmund K Waller; Jonathan Murrow; Fabio Esteves; James Galt; John Oshinski; Stamatios Lerakis; Salman Sher; Douglas Vaughan; Emerson Perin; James Willerson; Dean Kereiakes; Bernard J Gersh; Douglas Gregory; Astrid Werner; Thomas Moss; Wai Shun Chan; Robert Preti; Andrew L Pecora
Journal:  Am Heart J       Date:  2011-01       Impact factor: 4.749

4.  Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?

Authors:  Cristina Sanina; Joshua M Hare
Journal:  Circ Res       Date:  2015-07-17       Impact factor: 17.367

Review 5.  Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.

Authors:  Muhammad R Afzal; Anweshan Samanta; Zubair I Shah; Vinodh Jeevanantham; Ahmed Abdel-Latif; Ewa K Zuba-Surma; Buddhadeb Dawn
Journal:  Circ Res       Date:  2015-07-09       Impact factor: 17.367

Review 6.  Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.

Authors:  Robert D Simari; Carl J Pepine; Jay H Traverse; Timothy D Henry; Roberto Bolli; Daniel B Spoon; Ed Yeh; Joshua M Hare; Ivonne Hernandez Schulman; R David Anderson; Charles Lambert; Shelly L Sayre; Doris A Taylor; Ray F Ebert; Lemuel A Moyé
Journal:  Circ Res       Date:  2014-05-09       Impact factor: 17.367

7.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

8.  Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.

Authors:  John Terrovitis; Riikka Lautamäki; Michael Bonios; James Fox; James M Engles; Jianhua Yu; Michelle K Leppo; Martin G Pomper; Richard L Wahl; Jurgen Seidel; Benjamin M Tsui; Frank M Bengel; M Roselle Abraham; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

Review 9.  The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia.

Authors:  Haruki Sekiguchi; Masaaki Ii; Douglas W Losordo
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

Review 10.  Reducing myocardial infarct size: challenges and future opportunities.

Authors:  Heerajnarain Bulluck; Derek M Yellon; Derek J Hausenloy
Journal:  Heart       Date:  2015-12-16       Impact factor: 5.994
View more
  9 in total

1.  A mechanistic roadmap for the clinical application of cardiac cell therapies.

Authors:  Eduardo Marbán
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

2.  Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction.

Authors:  Bo-Fang Zhang; Hong Jiang; Jing Chen; Qi Hu; Shuo Yang; Xiao-Pei Liu
Journal:  J Cell Physiol       Date:  2019-04-14       Impact factor: 6.384

Review 3.  VEGF-A in Cardiomyocytes and Heart Diseases.

Authors:  Mariantonia Braile; Simone Marcella; Leonardo Cristinziano; Maria Rosaria Galdiero; Luca Modestino; Anne Lise Ferrara; Gilda Varricchi; Giancarlo Marone; Stefania Loffredo
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

Review 4.  Connecting different heart diseases through intercellular communication.

Authors:  Tania Martins-Marques
Journal:  Biol Open       Date:  2021-09-08       Impact factor: 2.422

5.  Mesenchymal Stromal Cells Overexpressing Farnesoid X Receptor Exert Cardioprotective Effects Against Acute Ischemic Heart Injury by Binding Endogenous Bile Acids.

Authors:  Yunlong Xia; Xinyue Xu; Yongzhen Guo; Chen Lin; Xiaoming Xu; Fuyang Zhang; Miaomiao Fan; Tingting Qi; Congye Li; Guangyu Hu; Lu Peng; Shan Wang; Ling Zhang; Chunxu Hai; Rui Liu; Wenjun Yan; Ling Tao
Journal:  Adv Sci (Weinh)       Date:  2022-07-03       Impact factor: 17.521

6.  TWEAK promotes endothelial progenitor cell vasculogenesis to alleviate acute myocardial infarction via the Fn14-NF-κB signaling pathway.

Authors:  Zulong Sheng; Chenwei Ju; Bing Li; Zhongpu Chen; Xiaodong Pan; Gaoliang Yan; Yanru He; Yuyu Yao; Genshan Ma
Journal:  Exp Ther Med       Date:  2018-09-06       Impact factor: 2.447

7.  IGF-1C domain-modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI.

Authors:  Yong Yao; Liang Yang; Li-Feng Feng; Zhi-Wei Yue; Nian-Huan Zhao; Zongjin Li; Zuo-Xiang He
Journal:  Stem Cell Res Ther       Date:  2020-03-26       Impact factor: 6.832

8.  Transplantation of hMSCs Genome Edited with LEF1 Improves Cardio-Protective Effects in Myocardial Infarction.

Authors:  Hyun-Min Cho; Kang-Hoon Lee; Yi-Ming Shen; Tae-Jin Shin; Pan-Dong Ryu; Min-Cheol Choi; Kyung-Sun Kang; Je-Yoel Cho
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-18       Impact factor: 8.886

Review 9.  Chitosan as Functional Biomaterial for Designing Delivery Systems in Cardiac Therapies.

Authors:  Bhaumik Patel; Ravi Manne; Devang B Patel; Shashank Gorityala; Arunkumar Palaniappan; Mallesh Kurakula
Journal:  Gels       Date:  2021-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.